BIO Competitors & Rivals
Compare Bio-Rad Laboratories Inc with top Medical Devices companies
Bio-Rad Laboratories Inc
BIO - Healthcare
Market Cap
$8.7B
Price
$322.17
P/E Ratio
N/A
Revenue Growth
0.0%
Top Competitors
Side-by-Side Comparison
| Metric | BIO | AAPL | MSFT | GOOGL |
|---|---|---|---|---|
| Price | $322.17 | $261.05 | $470.67 | $335.97 |
| Market Cap | $8.7B | $3874.1B | $3498.6B | $4063.2B |
| P/E Ratio | N/A | 33.85 | 33.89 | 32.79 |
| Revenue Growth | 0.0% | 6.4% | 0.2% | 0.2% |
| Profit Margin | -0.3% | 0.3% | 0.4% | 0.3% |
Detailed Head-to-Head Comparisons
Get in-depth analysis comparing BIO with each competitor
Frequently Asked Questions
Who are BIO's main competitors?
BIO's main competitors include AAPL, MSFT, GOOGL, and other companies in the Medical Devices industry. These companies compete directly with Bio-Rad Laboratories Inc for market share and customers.
How does BIO compare to its competitors?
BIO can be compared to competitors using metrics like market capitalization, P/E ratio, revenue growth, profit margins, and market share. Each competitor has different strengths - some may have better valuations while others have higher growth rates.
What are the best alternatives to BIO stock?
The best alternatives to BIO depend on your investment goals. For similar market exposure, consider AAPL or MSFT. For different risk profiles, research companies with varying market caps and growth trajectories in the Medical Devices sector.
Which is better: BIO or AAPL?
Comparing BIO vs AAPL requires analyzing valuation metrics, growth prospects, competitive advantages, and risk factors. Neither is universally "better" - the right choice depends on your investment strategy, risk tolerance, and market outlook.
What makes BIO different from its competitors?
Bio-Rad Laboratories Inc differentiates itself through its unique business model, product offerings, market positioning, and competitive advantages. Factors like brand strength, innovation, operational efficiency, and financial health distinguish BIO from rivals.
Should I diversify across BIO and its competitors?
Diversifying across multiple companies in the same industry can reduce company-specific risk while maintaining sector exposure. However, this doesn't eliminate sector risk. Consider diversifying across different industries and sectors for better risk-adjusted returns.
Continue Your Research
Explore more analysis tools for BIO